cliffwatch

Applicant, as named in the Orange Book

Janssen R And D

Johnson & Johnson · NYSE: JNJ

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Products with listed protection

DrugEarliest generic entry

None.

Recent events

  • Intelence · Generic approved · ANDA 219152, BionpharmaApproved 2 Oct 2025Detected 25 Oct 2026
Products without listed protection (1)
DrugEarliest generic entry
Intelence
NDA 022187 · 3 strengths
etravirine
open now
no listed protection